• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPHMB
Pharmacom Biovet Inc
860.0
0.0x
---
United StatesACNV
Accelera Innovations Inc
80.0
0.0x
---
United StatesBTGN
Bitcoin Generation Inc
25.4K
0.0x
---
United StatesPZOO
Pazoo Inc
2.7K
---
---
United StatesEWLL
American Health Protection Corp
18.5K
0.0x
---
United StatesCGHC
Capital Group Holdings Inc
9.2K
0.0x
---
As of 2024-11-12

Company Information

PharmaCom BioVet Inc., formerly ABV Gold Inc., intends to introduce and further develop bone marrow transplantation and other cancer treatment procedures to benefit companion animals (canine and feline) that are diagnosed with lymphoma, other types of cancers and other diseases. The Company is introducing canine bone marrow transplantation. ABV Gold Inc. was a gold and precious metals mining company founded as an exploration company to locate, explore and mine deposits. The Company holds claims in three different properties: The Toiyabe Uranium, the Parin Mining, and the Dun Glen properties.

Contact Information

Headquarters
6040-A Six Forks Road, Suite 135RALEIGH, NC, United States 27609
Phone
919-604-4887
Fax
919-846-9225

Executives

President
Daniel Ryan
Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
Peter Preston
President of Plan B Productions of Utah, Inc, Director
Russell Heaton
Director
Enzo Vettese

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$860.00
Revenue (TTM)
$0.00
Shares Outstanding
856.1M
Pharmacom Biovet Inc does not pay a dividend.
Beta
---
EPS
$-0.99
Book Value
$0.19
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.